Updated: May 22, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
R L Margraf1, J D Durtschi, J E Stephens
1Research & Development, ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers discovered novel genetic variations in the RET proto-oncogene using next-generation sequencing (NGS) in individuals without multiple endocrine neoplasia type 2 (MEN2). These findings contribute valuable data to the RET MEN2 database for future research.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: